By A Mystery Man Writer
Breast re-irradiation (reRT) after breast-conserving surgery (BCS) using external beam radiation is an increasingly used salvage approach for women presenting with recurrent or new primary breast cancer. However, radiation technique, dose and fractionation as well as eligibility criteria differ between studies. There is also limited data on efficacy and safety of external beam hypofractionation and accelerated partial-breast irradiation (APBI) regimens. This paper reviews existing retrospective and prospective data for breast reRT after BCS, APBI reRT outcomes and delivery at our institution and the need for a randomized controlled trial using shorter courses of radiation to better define patient selection for different reRT fractionation regimens.
Handpicked for you: sessions for pharmacists at Oncology
Current Oncology, Free Full-Text
NEJM on X: Get the latest research in Hematology/Oncology reports at / X
Oncology Nursing Society
LUNGevity Foundation on LinkedIn: #lcsm #livingwithlungcancer
Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours, destiny roleplay register
Current Oncology, Free Full-Text
Cancer Research News American Cancer Society
Current Oncology, Free Full-Text, Skin Tone Construction Paper
Current Oncology, Free Full-Text